Host translation machinery (HTM)

The host translation machinery is the integrated system of ribosomes, transfer RNAs (tRNAs), and auxiliary protein factors (initiation, elongation, and termination factors) that execute the synthesis of proteins from messenger RNA (mRNA) templates. In the context of infectious diseases, viruses are obligate intracellular parasites that lack their own translational apparatus and must hijack the host's machinery to produce viral proteins, making components like eIF4A and eEF1A critical nodes for broad-spectrum antiviral intervention (Science, 2021, PMID: 33495306). In oncology, many tumors exhibit dysregulated translation, often characterized by the overactivation of the eIF4F complex, which selectively enhances the translation of pro-survival and pro-growth oncogenes (Nature Reviews Drug Discovery, 2018, PMID: 29449665). Drugs targeting this machinery, such as Zotatifin (targeting eIF4A) and Plitidepsin (targeting eEF1A2), aim to disrupt these pathological processes by inhibiting specific steps of the translation cycle (Frontiers in Genetics, 2020, PMID: 32353831). While promising, the fundamental necessity of protein synthesis for all living cells requires precise dosing and targeting to minimize systemic toxicity and maintain a viable therapeutic index.

Other names

Host protein synthesis machineryEukaryotic translation apparatusHost translational machineryRibosomal machineryEukaryotic protein synthesis system

Inhibition of the eIF4F initiation complex (specifically eIF4A helicase activity), inhibition of eukaryotic elongation factor 1 alpha (eEF1A), or indirect modulation via the mTORC1 pathway to suppress the translation of specific mRNA subsets (e.g., terminal oligopyrimidine tract mRNAs or highly structured 5' UTR mRNAs).